Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data
Rheumatology and Therapy
doi 10.1007/s40744-019-00183-6
Full Text
Abstract
Available in
Date
November 21, 2019
Authors
Publisher
Springer Science and Business Media LLC